Phase I Multiple Ascending Dose Study for AZD 7268 in Healthy Volunteers

A Phase I, Single-center, Double-blind, Randomized, Placebo-controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD7268 When Given in Multiple Ascending Oral Doses in Healthy Subjects

Multiple Ascending Dose Study

Inclusion Criteria:

• Provision of Informed Consent

• Healthy male subjects and female subjects (of non-child bearing potential)

  • with suitable veins for cannulation or repeated venipuncture

Exclusion Criteria:

• Inability to understand or cooperate with given information
• Any positive result on screening for human immune deficiency virus (HIV), Hepatitis B, or Hepatitis C test
• History of seizure (including infancy febrile seizures) or family history of seizure